| Title : Montelukast Ameliorates Scopolamine-induced Alzheimer's Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF - Yerraguravagari_2023_CNS.Neurol.Disord.Drug.Targets__ |
| Author(s) : Yerraguravagari B , Penchikala NP , Kolusu AS , Sandeep Ganesh G , Konduri P , Nemmani KVS , Samudrala PK |
| Ref : CNS Neurol Disord Drug Targets , : , 2023 |
| Abstract : Yerraguravagari_2023_CNS.Neurol.Disord.Drug.Targets__ |
| ESTHER : Yerraguravagari_2023_CNS.Neurol.Disord.Drug.Targets__ |
| PubMedSearch : Yerraguravagari_2023_CNS.Neurol.Disord.Drug.Targets__ |
| PubMedID: 37779395 |
Yerraguravagari B, Penchikala NP, Kolusu AS, Sandeep Ganesh G, Konduri P, Nemmani KVS, Samudrala PK (2023)
Montelukast Ameliorates Scopolamine-induced Alzheimer's Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF
CNS Neurol Disord Drug Targets
:
Yerraguravagari B, Penchikala NP, Kolusu AS, Sandeep Ganesh G, Konduri P, Nemmani KVS, Samudrala PK (2023)
CNS Neurol Disord Drug Targets
: